Burning Rock Biotech Limited American Depositary Receipt logo

Burning Rock Biotech Limited American Depositary Receipt (BNR)

Market Closed
14 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
11. 60
-0.68
-5.5375%
$
12.67M Market Cap
- P/E Ratio
- Div Yield
238,800 Volume
0 Eps
$ 12.28
Previous Close
Investors:
Add Transaction
Day Range
10.7 12.37
Year Range
6.79 41.72
Want to track BNR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Burning Rock Biotech Limited American Depositary Receipt (BNR) Statistics

Valuation metrics

Market Cap 12.67M
Enterprise value -287.07M
Trailing P/E (ttm) -1.28
Forward P/E -28.79
PEG ratio -0.03
Price/Sales (ttm) 0.17
Price/Book (mrq) 0.18
Enterprise Value/Revenue -0.57
Enterprise Value/EBITDA 6.8

Overview

Shares outstanding 105.18M
Float 40.74M
Shares short 47.58K
% Held by insiders 0.04%
% Held by institutions 0.47%
Average volume (10 days) 50.9K
Average volume (90 days) 21.55K

Price summary

52-Week low 6.79
52-Week high 41.72
Beta 1.5
50-Day moving average 9.61
200-Day moving average 16.76

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 15 May 2024

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -0.14%
Operating margin -0.13%

Operational effectiveness

Return on assets -0.09%
Return on equity -0.13%

Income Statement

Revenue (ttm) 79.26M
Revenue per share (ttm) 461.11
Quarterly revenue growth (yoy) 0%
Gross profit (ttm) 59.19M
EBITDA -4.88M
Net income to common (ttm) -8.13M
Diluted EPS (ttm) -62.65
Quarterly earnings growth (yoy) 0%

Balance Sheet

Total cash (mrq) 70.63M
Total cash per share (mrq) 386.04
Total debt (mrq) 6.33M
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 3.03%
Book value per share (mrq) 457.86

Cash Flow

Cash flow statement -4.18M
Levered free cash flow (LFCF) -3.35M